Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial. [electronic resource]
Producer: 20200629Description: 206-217 p. digitalISSN:- 1552-4604
- Adult
- Antidepressive Agents -- therapeutic use
- Buprenorphine -- adverse effects
- Cross-Over Studies
- Depressive Disorder, Major -- drug therapy
- Double-Blind Method
- Drug Therapy, Combination -- adverse effects
- Female
- Humans
- Male
- Middle Aged
- Naltrexone -- adverse effects
- Narcotic Antagonists -- adverse effects
- Opioid-Related Disorders
- Placebos
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.